Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Tevogen Bio Holdings Inc
TVGN
Healthcare
Biotechnology
Tevogen Bio Holdings Inc. is a clinical-stage specialty immunotherapy company. The Company is harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs), to develop off-the-shelf, genetically unmodified precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders, aiming to address the unmet needs of patient populations. Its first product candidate, TVGN 489...
, is an off-the-shelf, allogeneic cytotoxic CD8+ T cell therapy designed to fill a critical gap in COVID-19 therapeutic solutions for the immunocompromised and the high-risk elderly, with potential applications in both treatment and prevention of Long COVID. In addition to TVGN 489, it has several product candidates under early-stage development. The Company is developing Epstein-Barr virus (EBV) specific CTLs for potential use in multiple sclerosis (MS) and EBV-associated lymphomas. Its TVGN 601 is being developed for MS, and its TVGN 930 is being developed for EBV-associated lymphomas.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:TVGN)
New Post
View:
Posts & Comments
Threaded Posts
(279)
•••
whytestocks
X
Post by
whytestocks
on Dec 05, 2024 10:45pm
Dr. Ryan Saadi Commends Individuals Who Dedicate Time to Pub
JUST IN: $TVGN Dr. Ryan Saadi Commends Individuals Who Dedicate Time to Public Service, and Congratulates Mayor Victor Sordillo on His Induction Into the NJ League of Municipalities Hall of FameWARREN
...more
(97)
•••
coolfooldumbguy
X
Post by
coolfooldumbguy
on Oct 21, 2024 10:27am
This stock is still cheap.
It's looking good for shareholders today of this one.
(97)
•••
coolfooldumbguy
X
Comment by
coolfooldumbguy
on Oct 18, 2024 2:47pm
RE:Been following TVGN closely since the Phase 1 results
This is a bargain stock,so that my buy order at $1.65cents per share is a good entry position for me.Glta shareholders.
(77)
•••
sdhaka
X
Post by
sdhaka
on Jul 10, 2024 5:53pm
🔦 Spotlight on TEVOGEN BIO:
The healthcare industry is experiencing remarkable growth, driven by cutting-edge technologies and a rising demand for advanced treatments. Innovations in hashtag#biotechnology and pharmaceuticals
...more
(77)
•••
sdhaka
X
Post by
sdhaka
on Jul 03, 2024 5:58pm
Tevogen Bio's cell therapy scores big in top journal.
Hey folks, I came across some news for Tevogen Bio Holdings (TVGN). Their phase I clinical trial results for TVGN 489 were just published in the prestigious Blood Advances journal, a
...more
(77)
•••
sdhaka
X
Post by
sdhaka
on Jun 27, 2024 2:56pm
Been following TVGN closely since the Phase 1 results
Hey everyone, Been following TVGN closely since the Phase 1 results for their COVID-19 treatment. Really impressed with the potential of their off-the-shelf CTL therapy – treating hundreds
...more
(77)
•••
sdhaka
X
Post by
sdhaka
on Jun 19, 2024 7:53pm
Analyst report on Tevogen Bio Holdings Inc!
Tevogen Bio Holdings Inc.: Fast Tracking a Potential Breakthrough for Treating Viral Infections and Cancer: [url=https://www.researchfrc.com/content/reports/post/104/fast-tracking-a-potential
...more
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
ReGen III Appoints New CEO and President to Accelerate Commercial and Strategic Opportunities
Introducing the NEW DealRoom: Your Gateway to Capital-Raising Investments
Are PGM mining stocks an attractive area for your next portfolio allocation?